AfoliOpen Afoli →

Teriflunomide

Teriflunomide is an active ingredient of the class «immunosuppressive drug».

Open in Afoli Medicines →

Chemical compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

Boxed warning (US label)

HEPATOTOXICITY and EMBRYOFETAL TOXICITY Hepatotoxicity Clinically significant and potentially life-threatening liver injury, including acute liver failure requiring transplant, has been reported in patients treated with AUBAGIO in the postmarketing setting.

What it is used for

AUBAGIO ® is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

US label

AUBAGIO is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (MS) (please refer to section 5.1 for important information on the population for which efficacy has been established).

EMA

How it works

Class: immunosuppressive drug

Common side effects

The following clinically significant adverse reactions are described elsewhere in the prescribing information: Hepatotoxicity Bone Marrow Effects/Immunosuppression Potential/Infections Hypersensitivity Reactions Serious Skin Reactions Drug Reaction with Eosinophilia and Systemic Symptoms Cutaneous or Mucocutaneous…

US label

Who should not take it

Severe hepatic impairment Pregnancy Hypersensitivity Current leflunomide treatment AUBAGIO is contraindicated in/with: Patients with severe hepatic impairment.

US label

Pregnancy and breastfeeding

AUBAGIO is contraindicated for use in pregnant women and females of reproductive potential not using effective contraception because of the potential for fetal harm based on animal data.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Aubagio

European Union

Aubagio · Teriflunomide Accord · Teriflunomide Viatris (previously Teriflunomide Mylan)

Canada

Apo-Teriflunomide · Auro-Teriflunomide · Jamp Teriflunomide · M-Teriflunomide · Nat-Teriflunomide · Pms-Teriflunomide · Sandoz Teriflunomide · Teva-Teriflunomide

Other trade names

Teriflunomide mylan

Approval status

US Food and Drug Administration
prescription · since 2012
European Medicines Agency
authorised · since 2013
Health Canada
prescription · marketed
First approval anywhere
2012

Codes

ATC
L04AA31, L04AK02
RxNorm CUI
1310520
ChEMBL
CHEMBL973
PubChem CID
54684141
UNII
1C058IKG3B
Wikidata
Q3077133

Frequently asked questions

What is Teriflunomide used for?

Teriflunomide is used for: Multiple sclerosis and Relapsing-remitting multiple sclerosis.

What kind of medicine is Teriflunomide?

Teriflunomide is an active ingredient of the class «immunosuppressive drug».

What are the brand names of Teriflunomide?

Brand names of Teriflunomide include Aubagio, Teriflunomide Accord, Teriflunomide Viatris (previously Teriflunomide Mylan), Apo-Teriflunomide, Auro-Teriflunomide, Jamp Teriflunomide, M-Teriflunomide, and Nat-Teriflunomide.

Medicines in the same class

Sources and licences

Updated November 15, 2026